Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Diane M Karl"'
Autor:
Matthew C. Riddle, Diane M. Karl
Publikováno v:
Diabetes Care. 35:2100-2107
Four years ago, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was stopped early as the result of increased mortality associated with intensive glycemic treatment of a population with type 2 diabetes (T2DM) and high cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8d6d32def7959a988858c028edcf6c1
https://doi.org/10.2337/dc12-0650
https://doi.org/10.2337/dc12-0650
Autor:
Diane M. Karl
Publikováno v:
Current Diabetes Reports. 4:352-357
Attention to meal-related insulin replacement in type 2 diabetes is important as insulin deficiency progresses. The physiology in type 2 and type 1 diabetes differs, and optimal use of basal-bolus therapy in type 2 diabetes requires attention to such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d73ed0a93538d670ad4d5df48887613
https://doi.org/10.1007/s11892-004-0037-1
https://doi.org/10.1007/s11892-004-0037-1
Autor:
Patrick J. O'Connor, Timothy E. Craven, Ulrich K. Schubart, William C. Cushman, Jorge Calles-Escandon, Irene Hramiak, Lois A. Katz, Jeffrey L. Probstfield, Faramarz Ismail-Beigi, Saul Genuth, Diane M. Karl, Hertzel C. Gerstein
Publikováno v:
Kidney international. 81(6)
A reduction of either blood pressure or glycemia decreases some microvascular complications of type 2 diabetes, and we studied here their combined effects. In total, 4733 older adults with established type 2 diabetes and hypertension were randomly as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0507113d3057c68b1935c9b193c546a
https://pubmed.ncbi.nlm.nih.gov/23070509
https://pubmed.ncbi.nlm.nih.gov/23070509
Autor:
Athena Philis-Tsimikas, Karen Lutz, Juan P. Frias, Tamara Darsow, Gayle M. Lorenzi, Terrie Kellmeyer, Diane M. Karl, Yan Wang
Publikováno v:
Diabetes technologytherapeutics. 9(2)
This study was designed to assess the safety and efficacy of pramlintide therapy in patients with type 2 diabetes in a clinical practice setting.In this open-label study, 166 insulin-treated patients with type 2 diabetes added pramlintide therapy (12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14111ef42d613641a4b10d7f97e98567
https://pubmed.ncbi.nlm.nih.gov/17425446
https://pubmed.ncbi.nlm.nih.gov/17425446
Publikováno v:
Endocrine Practice. 11:22-23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c49dd2d4db699762eb64210b4189bd0
https://doi.org/10.1016/s1530-891x(20)43677-8
https://doi.org/10.1016/s1530-891x(20)43677-8
Autor:
Diane M. Karl
Publikováno v:
Clinical Diabetes. 19:24-25
C.M. is a 36-year-old Spanish-speaking Mexican-American woman with a 3-year history of type 2 diabetes. She was seen in her primary physician’s office because of a missed menstrual period; a pregnancy test was positive. Her past obstetrical history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c835c0fa75c9c1b2a379f7ed6ddb43e1
https://doi.org/10.2337/diaclin.19.1.24
https://doi.org/10.2337/diaclin.19.1.24
Publikováno v:
Clinical pharmacology and therapeutics. 12(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee8419276456843e73a01699a8450e5
https://pubmed.ncbi.nlm.nih.gov/5208911
https://pubmed.ncbi.nlm.nih.gov/5208911
Publikováno v:
American Heart Journal. 106:1160-1161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f95c46f169fdbca493bef60f9c0a929
https://doi.org/10.1016/0002-8703(83)90670-1
https://doi.org/10.1016/0002-8703(83)90670-1
Autor:
Cepoi, Vasile1, Alexa, Ioana Dana1 ioana.b.alexa@gmail.com, Ilie, Adina Carmen1, Alexa, Ovidiu1
Publikováno v:
Revista Romana de Bioetica. jul-sep2014, Vol. 12 Issue 3, p12-18. 7p.